F5 Inc
FFIV
466.65
-3.14
-0.67%
F5 Inc
US · FFIV
#783 by market cap
Listed 1970
466.65
-3.14
-0.67%
Live - 5344 symbols - heartbeat 285s ago
· 2026-10-08 07:00
Pre-market
465.00
-0.35%
After-hours
466.65
0.00%
- Market cap
- 26.43B
- P/E (TTM)i
- 37.18
- P/Bi
- 6.85
- EPSi
- 11.80
- Div yieldi
- 0.00%
- 52W posi
- 98%
Reader sentiment
Are you bullish or bearish on FFIV?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 7.68, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +9.66% YoY
Margins
- Gross margin
- 81.41%
- Operating margin
- 25.63%
- Net margin
- 22.42%
Key ratios & quality
- PEG ratioi
- 1.28
- Altman Z-Scorei
- 7.68
PEG uses trailing P/E against the 3-year net income growth rate (29.05%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.16B | 2.24B | 2.35B | 2.60B | 2.70B | 2.81B | 2.82B | 3.09B |
| Gross profit | 1.80B | 1.89B | 1.94B | 2.11B | 2.16B | 2.22B | 2.26B | 2.51B |
| Selling & admin expenses | 824.52M | 959.35M | 1.10B | 1.20B | 1.20B | 1.14B | 1.10B | 1.18B |
| Research & development | 366.08M | 408.06M | 441.32M | 512.63M | 543.37M | 540.29M | 490.12M | 539.82M |
| Operating profit | 609.33M | 518.46M | 400.07M | 394.03M | 411.70M | 537.96M | 667.25M | 791.43M |
| Pretax profit | 603.76M | 541.11M | 396.40M | 386.94M | 385.39M | 485.99M | 695.47M | 808.34M |
| Tax | 150.07M | 113.38M | 88.96M | 55.70M | 63.23M | 91.04M | 128.69M | 115.96M |
| Net profit | 453.69M | 427.73M | 307.44M | 331.24M | 322.16M | 394.95M | 566.78M | 692.38M |
| Basic EPS | 7 | 7 | 5 | 5 | 5 | 7 | 10 | 12 |
| Diluted EPS | 7.32 | 7.08 | 5.01 | 5.34 | 5.27 | 6.55 | 9.55 | 11.80 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 731.12M | 780.37M | 810.09M | 822.47M | 811.70M | 865.08M |
| Gross profit | 590.16M | 631.74M | 666.21M | 670.68M | 660.80M | 711.51M |
| Selling & admin expenses | 294.71M | 299.08M | 310.00M | 315.38M | 331.06M | 333.62M |
| Research & development | 136.56M | 136.35M | 136.39M | 141.16M | 151.04M | 164.66M |
| Operating profit | 158.90M | 196.32M | 219.82M | 214.14M | 178.70M | 213.24M |
| Pretax profit | 171.20M | 213.02M | 215.07M | 222.92M | 189.22M | 226.20M |
| Tax | 25.67M | 23.11M | 24.58M | 42.87M | 41.46M | 17.99M |
| Net profit | 145.53M | 189.91M | 190.49M | 180.05M | 147.76M | 208.21M |
| Basic EPS | 3 | 3 | 3 | 3 | 3 | 4 |
| Diluted EPS | 2.48 | 3.25 | 3.26 | 3.10 | 2.58 | 3.62 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 1.42B | 1.51B | 1.79B | 1.61B | 1.91B | 1.85B | 2.11B | 2.52B |
| Cash & ST investments | 1.04B | 972.28M | 1.21B | 910.61M | 884.57M | 803.32M | 1.07B | 1.34B |
| Inventory | 30.57M | 34.40M | 27.90M | 22.06M | 68.37M | 35.87M | 76.38M | 77.23M |
| Total assets | 2.61B | 3.39B | 4.68B | 5.00B | 5.28B | 5.25B | 5.61B | 6.32B |
| Total current liabilities | 954.43M | 1.11B | 1.29B | 1.39B | 1.84B | 1.47B | 1.49B | 1.61B |
| Short-term debt | -- | -- | 65.29M | 68.56M | 392.30M | 41.42M | 33.78M | 31.04M |
| Long-term debt | -- | -- | 369.05M | 349.77M | -- | -- | -- | -- |
| Total liabilities | 1,319,984,000.00 | 1,628,778,000.00 | 2,445,652,000.00 | 2,637,067,000.00 | 2,807,216,000.00 | 2,448,101,000.00 | 2,483,626,000.00 | 2,727,493,000.00 |
| Total equity | 1.29B | 1.76B | 2.23B | 2.36B | 2.47B | 2.80B | 3.13B | 3.59B |
| Retained earnings | 1.29B | 1.64B | 1.95B | 2.19B | 2.40B | 2.80B | 3.14B | 3.57B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 2.34B | 2.49B | 2.52B | 2.52B | 2.70B | 2.95B |
| Cash & ST investments | 1.26B | 1.43B | 1.34B | 1.20B | 1.44B | 1.61B |
| Inventory | 67.88M | 66.92M | 77.23M | 79.90M | 90.30M | 126.89M |
| Total assets | 5.91B | 6.11B | 6.32B | 6.29B | 6.50B | 6.83B |
| Total current liabilities | 1.52B | 1.55B | 1.61B | 1.62B | 1.68B | 1.77B |
| Short-term debt | 30.20M | 30.41M | 31.04M | 32.86M | 33.28M | 33.68M |
| Long-term debt | -- | -- | -- | -- | -- | -- |
| Total liabilities | 2,592,532,000.00 | 2,641,815,000.00 | 2,727,493,000.00 | 2,753,418,000.00 | 2,847,897,000.00 | 2,973,345,000.00 |
| Total equity | 3.31B | 3.47B | 3.59B | 3.54B | 3.65B | 3.86B |
| Retained earnings | 3.30B | 3.45B | 3.57B | 3.55B | 3.62B | 3.82B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 761.07M | 747.84M | 660.90M | 645.20M | 442.63M | 653.41M | 792.42M | 949.67M |
| Depreciation & amortization | 59.49M | 68.51M | 95.86M | 115.42M | 115.61M | 112.70M | 106.99M | 92.40M |
| Free cash flow | 707.60M | 644.30M | 600.96M | 614.55M | 409.01M | 599.23M | 762.01M | 906.41M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -600.08M | -201.05M | -100.02M | -500.00M | -500.02M | -350.05M | -500.56M | -502.09M |
| Ending cash balance | 425.89M | 602.25M | 852.83M | 584.33M | 762.21M | 800.84M | 1.08B | 1.35B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 256.60M | 282.22M | 208.07M | 159.21M | 365.92M | 316.25M |
| Depreciation & amortization | 22.47M | 22.47M | 24.79M | 24.61M | 24.57M | 23.43M |
| Free cash flow | 246.09M | 273.68M | 191.93M | 149.49M | 347.57M | 280.61M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -127.06M | -125.01M | -125.01M | -301.10M | -100.01M | -100.01M |
| Ending cash balance | 1.26B | 1.43B | 1.35B | 1.20B | 1.44B | 1.61B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 36.08 | 28.08 | 15.40 | 14.43 | 13.34 | 14.99 | 19.12 | 20.60 |
| ROA %i | 17.84 | 14.27 | 7.62 | 6.85 | 6.27 | 7.51 | 10.44 | 11.60 |
| ROIC %i | 36.08 | 28.08 | 11.10 | 10.89 | 10.38 | 12.71 | 17.55 | 19.15 |
| 5-year avg ROE %i | 29.75 | 31.09 | 28.73 | 25.77 | 21.46 | 17.25 | 15.45 | 16.50 |
| EBIT margin %i | 28.19 | 23.12 | 17.02 | 15.13 | 15.27 | 19.12 | 23.69 | 25.63 |
| FCF / sales %i | 32.74 | 28.73 | 25.56 | 23.61 | 15.17 | 21.30 | 27.06 | 29.35 |
| Current ratioi | 1.49 | 1.37 | 1.39 | 1.16 | 1.04 | 1.26 | 1.42 | 1.56 |
| Quick ratioi | 1.40 | 1.24 | 1.28 | 1.05 | 0.91 | 1.11 | 1.25 | 1.40 |
| Debt / assetsi | -- | 0.00 | 16.53 | 14.31 | 12.60 | 5.35 | 4.45 | 4.14 |
| LT debt / equityi | -- | -- | 31.71 | 27.40 | 11.03 | 8.56 | 6.90 | 6.42 |
| Interest coveragei | -- | -- | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | 4.03 | 3.97 | 4.00 | 6.40 | 6.33 | 6.17 | 2.65 | 4.63 |
| Net income CAGR (3Y) %i | 7.52 | 5.35 | -9.93 | -9.95 | -9.02 | 8.71 | 19.61 | 29.05 |
| FCF CAGR (3Y) %i | 4.65 | 0.05 | -4.85 | -4.59 | -14.06 | -0.10 | 7.43 | 30.38 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 19.89 | 20.58 | 20.60 | 20.84 | 20.34 | 19.83 |
| ROA %i | 11.01 | 11.58 | 11.60 | 11.58 | 11.42 | 11.23 |
| ROIC %i | 18.33 | 19.05 | 19.15 | 19.30 | 18.91 | 18.53 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 24.82 | 25.21 | 25.63 | 25.10 | 25.09 | 24.96 |
| FCF / sales %i | 28.38 | 31.57 | 29.35 | 27.39 | 29.85 | 29.30 |
| Current ratioi | 1.53 | 1.60 | 1.56 | 1.55 | 1.61 | 1.66 |
| Quick ratioi | 1.36 | 1.45 | 1.40 | 1.36 | 1.42 | 1.48 |
| Debt / assetsi | 4.52 | 4.25 | 4.14 | 4.26 | 4.00 | 3.70 |
| LT debt / equityi | 7.14 | 6.61 | 6.42 | 6.64 | 6.21 | 5.67 |
| Interest coveragei | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Services is the largest reported line at 46.50% of revenue, across 3 reported segments.
- Systems revenue follows at 27.69%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Services46.50%
Systems revenue27.69%
Software revenue25.81%
Quote time 2026-10-08 07:00:03 · For reference only, not investment advice and not tailored to your situation.